Cambria Investment Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
26,445
+1,561
+6% +$76K 0.07% 237
2026
Q1
$1.07M Sell
24,884
-2,027
-8% -$87.1K 0.06% 224
2025
Q4
$1.18M Buy
26,911
+3,477
+15% +$144K 0.07% 220
2025
Q3
$968K Buy
23,434
+3,965
+20% +$159K 0.06% 222
2025
Q2
$858K Sell
19,469
-332
-2% -$13.3K 0.06% 196
2025
Q1
$731K Buy
+19,801
New +$706K 0.05% 151

Other funds holding EXEL

Cambria Investment Management's EXEL Position: Q2 2026 in Review

Cambria Investment Management increased its Exelixis (EXEL) stake by 6.3% in Q2 2026, buying an estimated $76K and bringing the position to 26,445 shares worth $1.44M. The position accounts for 0.07% of the portfolio, ranked #237.

Cambria Investment Management first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Cambria Investment Management held 26,445 shares of Exelixis worth $1.44M as of Q2 2026.
  • Cambria Investment Management bought 1,561 Exelixis shares in Q2 2026, an estimated $76K.
  • Exelixis made up 0.07% of Cambria Investment Management's portfolio in Q2 2026, its #237 holding.
  • Cambria Investment Management first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.